SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
A phase 3 trial of Oxaliplatin, Tegafur, gimeracil and oteracil and Capecitabine in Colorectal cancer, run by Peking University Cancer Hospital & Institute, with a status the registry has not verified recently.
Overview
SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients is a phase 3 interventional study registered as NCT03448549 by Peking University Cancer Hospital & Institute, with 1191 participants planned, started 2018-01-01 and due to reach its primary completion in 2021-01-01. Interventions recorded: Oxaliplatin, Tegafur，gimeracil and oteracil potassium, Xeloda. Conditions recorded: Colorectal Cancer Stage III, Adjuvant Chemotherapy.
Linked to the drug Tegafur, gimeracil and oteracil because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialTegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Shares Tegafur, gimeracil and oteracil (S-1), Colorectal cancer and the tag pipeline.
- TrialA Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
Shares Oxaliplatin, Capecitabine, Colorectal cancer and the tag pipeline.
- TrialOxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
Shares Oxaliplatin, Capecitabine, Colorectal cancer and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Oxaliplatin, Capecitabine and the tag pipeline.
- TrialA Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)
Shares Oxaliplatin, Capecitabine and the tag pipeline.
- TrialA Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
Shares Oxaliplatin, Capecitabine and the tag pipeline.
- TrialMR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
Shares Oxaliplatin, Capecitabine and the tag pipeline.
- TrialA Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
Shares Oxaliplatin, Capecitabine and the tag pipeline.